Related Experiment Videos

[Medication errors in pediatric inpatients: a multicentric prospective study]

C Stheneur1, J-B Armengaud, C Castro

  • 1Service de Pédiatrie, Assistance Publique-Hôpitaux de Paris, Hôpital Ambroise-Paré, 8, Avenue du Général-de-Gaulle, 92100 Boulogne-Billancourt, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|September 1, 2006
PubMed

Insights

Pediatric medication errors are frequent, involving both prescription and administration. Identifying contributing factors is crucial for developing targeted safety interventions in pediatric care.

Area of Science:

  • Pediatric pharmacology
  • Patient safety research
  • Healthcare quality improvement

Context:

  • Medication errors pose a significant risk in pediatric inpatient settings.
  • Understanding the frequency and characteristics of these errors is essential for improving care.
  • This study investigated medication errors across various pediatric wards.

Purpose:

  • To enhance understanding of pediatric medication error rates.
  • To characterize the nature and contributing factors of these errors.
  • To identify risk factors associated with medication errors in children.

Summary:

  • A prospective study analyzed 75 reports of medication errors in pediatric wards.
  • Errors primarily occurred during prescription (21 cases) and administration (45 cases).
  • Attributable factors were identified in 39 cases, including protocol non-adherence, lack of knowledge, and system flaws.

Impact:

  • Findings highlight the commonality of medication errors in pediatric inpatients.
  • Complex contributing factors necessitate comprehensive safety strategies.
  • Recommendations include developing robust medication safety programs and error reporting systems for pediatric patients.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...